Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 5,037 shares at $4.20 ($21K) on 2023-03-08, disclosed to the SEC on 2023-03-09.
Scheduled purchase ($21k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.23 | 1,961 | $8K | 39.1% |
| 2 | $4.20 | 3,076 | $13K | 60.9% |
| Total | $4.21 avg | 5,037 | $21K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |